Lanthanide Coordination Polymers with Soft-Base Ditopic Bisthiazolate Ligands.

In order to prepare the first lanthanide coordination polymers (CPs) based on ditopic sulfide ligands, benzo[1,2-d:4,5-d']bisthiazole-2,6(3H,7H)-dithione (H2L) was used as a linker. The reactions of lanthanide silylamides Ln[N(SiMe3)2]3 (Ln = Nd, Gd, Er, and Yb) with H2L result in the formation of soluble dimethyl sulfoxide (DMSO) ionic salts [Ln(DMSO)8][L]1.5 [Ln = Nd (1), Gd (2), Er (3), and Yb (4)]. Due to the lack of coordination of anionic ligands, compounds 1, 3, and 4 do not show sensitized metal-centered photoluminescence (PL), while Gd compound 2 shows weak phosphorescence at 77 K. It was found that the heating of 1 in a 1:9 DMSO/1,4-dioxane mixture leads to the formation of large crystals of 2D CP [Nd(DMSO)3L1.5·0.5diox]n (5), where deprotonated dithione H2L plays the role of a ditopic linker. This linker acts as an "antenna" in compound 5, providing an intense near-infrared (NIR) PL of Nd3+ ion upon near-UV and blue-light excitation. The application of a synthetic protocol similar to that of compounds 2-4 led to the formation of amorphous compounds [Ln(DMSO)3L1.5·0.5diox]n [Ln = Gd (6), Er (7), and Yb (8)], whose PL properties significantly differ from those of the parental ionic salts. In the case of Yb polymer 8, the PL excitation spectra are shifted to the red region due to a low-energy ligand-to-metal charge-transfer state. The synthesized compounds 5-8 are the first examples of lanthanide CPs using soft-base ditopic linkers in their structures.

Hyperprolactinemia and Antipsychotic Therapy in Schizophrenic Patients with Hashimoto's Thyroiditis.

INTRODUCTION: Hyperprolactinemia (HPRL) is known as a side effect of some antidepressants and antipsychotics. These medicines are common in treatment of schizophrenia. Thus, HPRL is often observed in schizophrenic patients. It is also known that HPRL can occur in Hashimoto's thyroiditis due to prolactoliberin effect of thyroliberin. The clinical pathophysiology of the patients with the comorbidity of schizophrenia and Hashimoto's thyroiditis, receiving antipsychotics, is of special interest. It's fair to assume that these patients have higher risks of HPRL. To analyze risks of HPRL with antipsychotic treatment, to identify an association between the antipsychotic therapy (AT) and HPRL in Hashimoto's patients receiving AT, to explore the association of HPRL and other laboratory parameters in patients with Hashimoto's thyroiditis and schizophrenia during AT. SUBJECTS AND METHODS: We studied 17 patients with HT in comorbidity with schizophrenia receiving AT (mean age 46.5±12.8 years), all euthyroid or with light hypothyroidism. Different laboratory parameters such as anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-TG) antibodies, blood levels of thyroid stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3) and prolactin (PRL) were analysed. RESULTS: The study revealed the high levels of PRL, anti-TPO and anti-TG autoantibodies. Thus, patients were classified into 3 groups by the degree of expected HPRL risk from the antipsychotics used: without expected risk, with low and high expected risks. The correlation analysis detected an inverse significant correlation (R=-0.51; p=0.037) between expected level of drug-associated HPRL risk and actual PRL levels in studied group. At the same time, we detected a positive significant correlation between the levels of PRL and FT4 in the groups (R=0.53; p=0.03). The correlations between the levels of PRL and other parameters such as TSH, FT3, anti-TPO, anti-TG, anti-TSH receptor antibodies were not statistically significant. CONCLUSIONS: HPRL in the group was not associated with taking of antipsychotic drugs with high expected HPRL risk. Yet, a significant positive correlation existed between the levels of PRL and FT4. Hence, in Hashimoto's thyroiditis accompanied with treated mental illness there are some non-iatrogenic stimulants of prolactogenesis. It cannot be ruled out that antipsychotics may interfere with prolactin metabolism, which creates a false effect of a positive correlation between prolactin and free thyroxine levels, in contrast to common HPRL of hypothyroidism.

A Small Cationic Organo-Copper Cluster as Thermally Robust Highly Photo- and Electroluminescent Material.

Organic light-emitting diodes (OLEDs) are revolutionizing display applications. In this aspect, luminescent complexes of precious metals such as iridium, platinum, or ruthenium still playing a significant role. Emissive compounds of earth-abundant copper with equivalent performance are desired for practical, large-scale applications such as solid-state lighting and displays. Copper(I)-based emitters are well-known to suffer from weak spin-orbit coupling and a high reorganization energy upon photoexcitation. Here we report a cationic organo-copper cluster [Cu4(PCP)3]+ (PCP = 2,6-(PPh2)2C6H3) that features suppressed nonradiative decays, giving rise to a robust narrow-band green luminophore with a photoluminescent (PL) efficiency up to 93%. PL decay kinetics corroborated by DFT calculations reveal a complex emission mechanism involving contributions of both thermally activated delayed fluorescence and phosphorescence. This robust compound was solution-processed into a thin film in prototype OLEDs with external quantum efficiency up to 11% and a narrow emission bandwidth (65 nm fwhm).

Features of the Molecular Structure and Luminescence of Rare-Earth Metal Complexes with Perfluorinated (Benzothiazolyl)phenolate Ligands.

A set of Sc, Nd, Sm, Eu, Ho, Gd, Er, Yb complexes with perfluorinated 2-(benzothiazol-2-yl)phenolate ligands Ln(SONF)3(DME) were synthesized by the reactions of silylamides Ln[N(SiMe3)2]3 with phenol H(SONF). The structure of the initial phenol, Sc, and Er complexes was established using X-ray analysis, which revealed that the obtained compounds are mononuclear, in contrast to the binuclear non-fluorinated analogues [Ln(SON)3]2 synthesized earlier. All the obtained complexes, both in solid state and in tetrahydrofuran (THF) solutions, upon excitation by light with λex 395 or 405 nm show intense luminance of the ligands at 440-470 nm. The Eu complex also exhibits weak metal-centered emission in the visible region, while the derivatives of Sm luminesces both in the visible and in the infrared region, and Nd, Er, and Yb complexes emit in the near IR (NIR) region of high intensity. DFT (density functional theory) calculation revealed that energy of frontier orbitals of the fluorinated complexes is lower than that of the non-fluorinated counterparts. The level of highest occupied molecular orbital (HOMO) decreases to a greater extent than the lowest occupied molecular orbital (LUMO) level.

The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study).

BACKGROUND: To assess the correlation between the antipsychotics (AP) mean daily doses, hospital stay duration and CYP2D6, DRD2 polymorphisms in naturalistic study. SUBJECTS AND METHODS: CYP2D6 polymorphisms *3, *4, *5, *6, *1XN and DRD2/ANKK1 Taq1A polymorphisms were genotyped in a cohort of 226 Caucasian schizophrenic inpatients. AP daily doses, hospital stay duration and AP treatment duration were taken from medical records. To compare mean daily doses of AP among CYP2D6 PMs, EMs, UMs and DRD2/ANKK1 Taq1A carriers the actual AP doses were converted to chlorpromazine (CPZ) equivalents and DDD (defined daily dose). RESULTS: Significant correlation (p=0.004) between CYP2D6 metabolic activity and AP mean daily doses was observed only among DRD2/ANKK1 Taq1A polymorphic allele carriers: 250.53 (95%CI: 154.90-346.17), 473.82 (95%CI: 426.99-520.64) 602.77 (95%CI: 469.65-735.88) CPZ equivalents in PMs, EMs and UMs, consequently. PMs with DRD2/ANKK1 Taq1A CT genotype received significantly lower doses of AP comparing to CC genotype (p=0.02). Mean hospital stay duration of PMs+UMs was significantly higher comparing to EMs (66.4 days (95% CI: 56.9-75.8) vs 50.2 days (95%CI: 45.5-54.7); p=0.047). CONCLUSIONS: In a cohort of schizophrenia inpatients CYP2D6 metabolic activity affects mean AP daily dose only in the presence of DRD2 Taq1A polymorphic allele. CYP2D6 metabolic activity correlates independently from DRD2 Taq1A polymorphism with hospital stay duration. Subpopulation of schizophrenia inpatients with altered CYP2D6 activity (PMs and UMs) carriers of Taq1A polymorphisms needs special attention of clinicians in aligning of AP treatment.

Luminescent properties of 2-mercaptobenzothiazolates of trivalent lanthanides.

A series of lanthanide complexes (Ln = Nd, Sm, Eu, Gd and Yb) with anionic 2-mercaptobenothiazolate (mbt) ligands were synthesized. Depending on the solvents chosen for the synthesis, Ln(mbt)3(THF)2 and Ln(mbt)3(Et2O) complexes were precipitated from THF and Et2O solutions respectively. The structure of Yb(mbt)3(Et2O) was determined by X-ray analysis. Photophysical properties of the complexes were studied. It was found that under photoexcitation Nd and Yb derivatives exhibit bright metal-centered luminescence in the NIR region while Sm(mbt)3(THF)2 demonstrates intensive visible emission corresponding to (4)G5/2 → (6)HJ (J = 5/2, 7/2, 9/2, 11/2) f-f transitions of Sm(3+) along with NIR emission of moderate intensity. In the case of europium compounds as well as Sm(mbt)3(Et2O) no luminescence was detected. It is assumed that the difference in photoluminescence of Yb and Eu complexes can be explained by an intramolecular electron transfer process, which efficiently proceeds in these compounds.

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.

Schizophrenia is a chronic, complex and heterogeneous mental disorder, with pathological features of disrupted neuronal excitability and plasticity within limbic structures of the brain. These pathological features manifest behaviorally as positive symptoms (including hallucinations, delusions and thought disorder), negative symptoms (such as social withdrawal, apathy and emotional blunting) and other psychopathological symptoms (such as psychomotor retardation, lack of insight, poor attention and impulse control). Altered glutamate neurotransmission has for decades been linked to schizophrenia, but all commonly prescribed antipsychotics act on dopamine receptors. LY404039 is a selective agonist for metabotropic glutamate 2/3 (mGlu2/3) receptors and has shown antipsychotic potential in animal studies. With data from rodents, we provide new evidence that mGlu2/3 receptor agonists work by a distinct mechanism different from that of olanzapine. To clinically test this mechanism, an oral prodrug of LY404039 (LY2140023) was evaluated in schizophrenic patients with olanzapine as an active control in a randomized, three-armed, double-blind, placebo-controlled study. Treatment with LY2140023, like treatment with olanzapine, was safe and well-tolerated; treated patients showed statistically significant improvements in both positive and negative symptoms of schizophrenia compared to placebo (P < 0.001 at week 4). Notably, patients treated with LY2140023 did not differ from placebo-treated patients with respect to prolactin elevation, extrapyramidal symptoms or weight gain. These data suggest that mGlu2/3 receptor agonists have antipsychotic properties and may provide a new alternative for the treatment of schizophrenia.

Infrared stimulated emission with an ultralow threshold from low-dislocation-density InN films grown on a vicinal GaN substrate.

Near-infrared stimulated emission from a high-quality InN layer under optical pumping was observed with a threshold excitation power density of 0.3 and 4 kW cm-2 at T = 8 and 77 K, respectively. To achieve such a low threshold power density, vicinal GaN substrates were used to reduce the edge-component threading dislocation (ETD) density of the InN film. Cross-sectional transmission electron microscopy images reveal that the annihilation of ETDs can be divided into two steps, and the ETD density can be reduced to approximately 5 × 108 cm-2 near the surface of the 5-µm-thick film. The well-resolved phonon replica of the band-to-band emission in the photoluminescence spectra at 9 K confirm the high quality of the InN film. As a result, the feasibility of InN-based photonic structures and the underlying physics of their growth and emission properties are demonstrated.

Optical Properties and Upconversion Luminescence of BaTiO3 Xerogel Structures Doped with Erbium and Ytterbium.

Erbium upconversion (UC) photoluminescence (PL) from sol-gel derived barium titanate (BaTiO3:Er) xerogel structures fabricated on silicon, glass or fused silica substrates has been studied. Under continuous-wave excitation at 980 nm and nanosecond pulsed excitation at 980 and 1540 nm, the fabricated structures demonstrate room temperature PL with several bands at 410, 523, 546, 658, 800 and 830 nm, corresponding to the 2H9/2 → 4I15/2, 2H11/2 → 4I15/2, 4S3/2 → 4I15/2, 4F9/2→ 4I15/2 and 4I9/2→ 4I15/2 transitions of Er3+ ions. The intensity of erbium UC PL increases when an additional macroporous layer of strontium titanate is used beneath the BaTiO3 xerogel layer. It is also enhanced in BaTiO3 xerogel films codoped with erbium and ytterbium (BaTiO3:(Er,Yb)). For the latter, a redistribution of the intensity of the PL bands is observed depending on the excitation conditions. A multilayer BaTiO3:(Er,Yb)/SiO2 microcavity structure was formed on a fused silica substrate with a cavity mode in the range of 650-680 nm corresponding to one of the UC PL bands of Er3+ ions. The obtained cavity structure annealed at 450 °C provides tuning of the cavity mode by 10 nm in the temperature range from 20 °C to 130 °C. Photonic application of BaTiO3 xerogel structures doped with lanthanides is discussed.

Luminescence thermochromism in novel mixed Eu(II)-Cu(I) iodide.

A new mixed Eu(II)-Cu(I) iodide [Eu(DME)4][Cu2I4] (1) was synthesized by the reaction of an organosulphide salt of Eu(II) and CuI in DME media. X-ray analysis revealed that 1 is an ate-complex consisting of Eu(DME)4 dications and tetraiododicuprate dianions. Upon UV light excitation (λ = 365 nm), the compound exhibits intense double-peaked photoluminescence (PL) at 445 and 500 nm. The relative intensity of these peaks changes dramatically when the temperature changes in the range of 180-250 K. To understand the nature of the found PL thermochromism, the structure and time-resolved PL of 1 were studied at various temperatures. The time-resolved PL studies of 1 at various temperatures revealed the presence of two luminescent centers which are excited by the capture of an electron from the conduction band. The ratio of intensities at 445 and 500 nm (R = I445/I500) in the PL spectra of 1 changes by almost two orders of magnitude and the relative sensitivity S (S = (∂R/∂T)/R) exceeds 5% per K in the range of 190-245 K that makes this compound a promising luminescent thermometer for the range where ammonia exists in a liquid state.

Synthesis, structure and long-lived NIR luminescence of lanthanide ate complexes with perfluorinated 2-mercaptobenzothiazole.

To obtain new efficient lanthanide-based NIR luminophores perfluorinated 2-mercaptobenzothiazole was used as a ligand. The ate-complexes [(Ln(mbtF)4)-(Na(DME)3)+] of Nd (1), Sm (2), Tb (3), Er (4), Yb (5) and [(Y(mbtF)4)-(Li(DME)3)+] (6) were synthesized in high yields by the reactions of the respective silylamide compounds Ln[N(SiMe3)2]3 and M[N(SiMe3)2] (M = Li, Na) with 4,5,6,7-tetrafluoro-1,3-benzothiazol-2(3H)-thione (HmbtF) in DME media. The complexes 1-3 and 6 were structurally characterized by X-ray diffraction analysis. It has been shown that the mbtF ligands sensitize the luminescence of Nd, Sm, Tb, Er and Yb ions upon mild UV or blue light excitation. The NIR luminescence of crystalline compounds 1, 2, 4 and 6 has been studied by time-resolved techniques. As expected, the compounds exhibit prolonged NIR luminescence due to the removal of C-H groups from lanthanide centers and the absence of C-O bonds in the coordination sphere of the lanthanides. The synthesized compounds are promising materials for NIR laser applications.

Sensitization of NIR luminescence of Yb3+ by Zn2+ chromophores in heterometallic complexes with a bridging Schiff-base ligand.

Herein, complexes [ZnL]2 (1), {(H2O)Zn(µ-L)Yb[OCH(CF3)2]3} (2), {[(CF3)2HCO]Zn(µ-L)Yb[OCH(CF3)2](µ-OH)}2 (3), and [(H2O)Ln2(L)3] (Ln = Yb (4) and Gd (5)) containing a bridging Schiff-base ligand (H2L = N,N'-bis(3-methoxy salicylidene)phenylene-1,2-diamine) were synthesized. The compounds 1-4 were structurally characterized. The ytterbium derivatives 2-4 exhibited bright NIR metal-centred photoluminescence (PL) of Yb3+ ion under one- (λex = 380 nm) and two-photon (λex = 750 nm) excitation. The superior luminescence properties of complex 2, which was suggested as a marker for NIR bioimaging, were explained via the strong absorption of the 375 nm LMCT state of the ZnL chromophore, efficient energy transfer from ZnL towards Yb3+ through a reversible ligand-to-lanthanide electron transfer process, and absence of luminescence quenchers (C-H and O-H groups) in the first coordination sphere of the rare-earth atom.

LMCT facilitated room temperature phosphorescence and energy transfer in substituted thiophenolates of Gd and Yb.

To obtain luminescent lanthanide complexes with a low energy LMCT state the 2-(2'-mercaptophenyl)benzothiazolates, Ln(SSN)3, and 2-(2'-mercaptophenyl)benzoxazolates, Ln2(OSN)6 (Ln = Gd, Yb), were synthesized by the reaction of amides Ln[N(SiMe3)2]3 with respective thiophenols. Ytterbium complexes were structurally characterized by X-ray diffraction analysis. Cyclic voltammetry revealed that the deprotonated mercaptophenyl ligands have significantly lower oxidation potentials than their phenoxy analogues and some ß-diketones. The photophysical properties of Gd and Yb compounds were studied both in solution and in the solid state. The fluorescence spectra of the compounds in solution display the bands of the keto and enol forms of the ligands. No energy transfer from the organic part to Yb3+ has been detected in solutions of both Yb complexes, whereas in solids an intense metal-centered emission in the near infrared region was observed. The solid Gd compounds exhibited room temperature phosphorescence caused by unusually efficient intersystem crossing facilitated by the essentially reducing properties of OSN and SSN ligands. To explain the sensitization process occurring in solids Yb2(OSN)6 and Yb(SSN)3 a specific non-resonant energy transfer mechanism via a ligand to metal charge transfer state has been proposed. Based on the Yb derivatives, NIR-emitting OLEDs with 860 µW cm-2 maximal irradiance were obtained. Their Gd counterparts showed bright electrophosphorescence (up to 1350 cd m-2) in the devices containing doped emission layers.